Related Experiment Video

Updated: Aug 18, 2026

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia
10:35

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia

Published on: September 20, 2015

Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET

K Ishii1, H Kitagaki, M Kono

  • 1Division of Neuroimaging Research, Hyogo Institute for Aging Brain and Cognitive Disorders, Himeji, Japan.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|July 1, 1996
PubMed
Abstract

Insights

Alzheimer's disease significantly impacts medial temporal lobe oxygen metabolism and blood flow, correlating with cognitive decline. This study clarifies these functional changes in early-stage Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Neurology

Background:

  • Previous PET studies showed no significant medial temporal lobe neurodegeneration in mild-to-moderate Alzheimer's disease (AD).
  • Understanding medial temporal functional changes is crucial for early AD diagnosis and treatment.

Purpose of the Study:

  • To investigate medial temporal perfusion and functional changes in mild-to-moderate AD using Positron Emission Tomography (PET).
  • To clarify the role of medial temporal lobe dysfunction in early-stage Alzheimer's disease.

Main Methods:

  • PET scans measured regional cerebral blood flow (CBF), oxygen metabolism (CMRO2), and oxygen extraction fraction (OEF) in 16 AD patients and 14 controls.
  • 15O steady-state method was employed for measurements.
  • Magnetic resonance volumetry assessed partial volume effects on PET data.

Main Results:

  • AD patients showed significantly lower medial temporal CMRO2 compared to controls.
  • CBF was reduced in parietal and lateral temporal cortices in AD patients.
  • Decreased medial temporal OEF in AD patients was observed, correlating with cognitive impairment scores.

Conclusions:

  • Medial temporal oxygen metabolism is significantly impaired in mild-to-moderate Alzheimer's disease.
  • These findings highlight medial temporal functional deficits as a key feature of early AD.
  • PET-based metabolic measures can substantiate functional impairment in the medial temporal region.

More Related Videos

Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level07:28

Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level

Published on: January 24, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-145105:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...